{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:30:07Z","timestamp":1764603007346},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.steroids.2011.02.012","type":"journal-article","created":{"date-parts":[[2011,2,26]],"date-time":"2011-02-26T12:15:28Z","timestamp":1298722528000},"source":"Crossref","is-referenced-by-count":10,"title":["Overlapping nongenomic and genomic actions of thyroid hormone and steroids"],"prefix":"10.1016","author":[{"given":"Paul J.","family":"Davis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Yun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaker A.","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary K.","family":"Luidens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleck A.","family":"Hercbergs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Wehling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faith B.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2011.02.012_bib0005","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1210\/er.2009-0007","article-title":"Molecular aspects of thyroid hormone actions","volume":"31","author":"Cheng","year":"2010","journal-title":"Endocr Rev"},{"key":"10.1016\/j.steroids.2011.02.012_bib0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev-pharmtox-010510-100512","article-title":"Membrane receptor for thyroid hormone: physiologic and pharmacologic implications","volume":"51","author":"Davis","year":"2011","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"10.1016\/j.steroids.2011.02.012_bib0015","doi-asserted-by":"crossref","first-page":"38032","DOI":"10.1074\/jbc.M002560200","article-title":"Thyroxine promotes association of mitogen-activated protein kinase (MAPK) and nuclear thyroid hormone receptor (TR) and causes serine phosphorylation of TR","volume":"275","author":"Davis","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.steroids.2011.02.012_bib0020","first-page":"2870","article-title":"Identification of the putative MAP kinase docking site in the thyroid hormone receptor \u03b21 DNA-binding domain: functional consequences of mutations at the docking site","volume":"40","author":"Lin","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.steroids.2011.02.012_bib0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/07435800903204082","article-title":"Cytoplasm-to-nucleus shuttling of thyroid hormone receptor \u03b21 (TR\u03b21) is directed from a plasma membrane integrin receptor by thyroid hormone","volume":"34","author":"Cao","year":"2009","journal-title":"Endocr Res"},{"key":"10.1016\/j.steroids.2011.02.012_bib0030","doi-asserted-by":"crossref","first-page":"27058","DOI":"10.1074\/jbc.273.42.27058","article-title":"Hormone-induced translocation of thyroid hormone receptors in living cells visualized using a receptor green fluorescent protein chimera","volume":"273","author":"Zhu","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.steroids.2011.02.012_bib0035","doi-asserted-by":"crossref","first-page":"12425","DOI":"10.1074\/jbc.M202752200","article-title":"Dynamic shuttling and intranuclear mobility of nuclear hormone receptors","volume":"278","author":"Maruvada","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.steroids.2011.02.012_bib0040","first-page":"e020","article-title":"Thyroid hormone mediated changes in gene expression can be initiated by cytosolic action of the thyroid hormone receptor \u03b2 through the phosphatidylinositol 3-kinase pathway","volume":"4","author":"Moeller","year":"2006","journal-title":"Nucl Recept"},{"key":"10.1016\/j.steroids.2011.02.012_bib0045","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1210\/en.2004-0308","article-title":"Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor","volume":"145","author":"Tang","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2011.02.012_bib0050","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.onc.1205136","article-title":"Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins, p53 and retinoblastoma, in breast cancer cells","volume":"21","author":"Dinda","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.steroids.2011.02.012_bib0055","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1126\/science.270.5241.1491","article-title":"Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase","volume":"270","author":"Kato","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.steroids.2011.02.012_bib0060","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1210\/en.2005-0102","article-title":"Integrin \u03b1v\u03b23 contains a cell surface receptor site for thyroid hormone that is linked to activation of MAPK and induction of angiogenesis","volume":"146","author":"Bergh","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2011.02.012_bib0065","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0092-8674(00)81717-1","article-title":"The structural basis of estrogen receptor\/coactivator recognition and the antagonism of this interaction by tamoxifen","volume":"95","author":"Shiau","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.steroids.2011.02.012_bib0070","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1093\/jnci\/djp412","article-title":"Estrogen receptor-\u03b1 phosphorylation at serine-118 and tamoxifen response in breast cancer","volume":"101","author":"Kok","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.steroids.2011.02.012_bib0075","first-page":"2336","article-title":"Effects of hypothyroidism on the induction and growth of mammary cancer induced by 7, 12-dimethylbenz(a)anthracene in the rat","volume":"40","author":"Goodman","year":"1980","journal-title":"Cancer Res"},{"key":"10.1016\/j.steroids.2011.02.012_bib0080","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.steroids.2006.11.014","article-title":"Thyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptotic","volume":"72","author":"Lin","year":"2007","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2011.02.012_bib0085","doi-asserted-by":"crossref","first-page":"C980","DOI":"10.1152\/ajpcell.00305.2008","article-title":"Thyroxine vs. 3,5,3\u2032-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase","volume":"296","author":"Lin","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.steroids.2011.02.012_bib0090","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1158\/0008-5472.CAN-05-4365","article-title":"Acting via cell surface receptor, thyroid hormone is a growth factor for glioma cells","volume":"66","author":"Davis","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.steroids.2011.02.012_bib0095","first-page":"617","article-title":"Propylthiouracil-induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high grade glioma: a phase I\/II study","volume":"23","author":"Hercbergs","year":"2003","journal-title":"Anticancer Res"},{"key":"10.1016\/j.steroids.2011.02.012_bib0100","article-title":"Hypothyroidism in patients with renal cell carcinoma: blessing or curse?","author":"Schmidinger","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.steroids.2011.02.012_bib0105","article-title":"The impact of sunitinib-induced hypothyroidism on progression-free survival of metastatic renal cancer patients: a prospective single-center study","author":"Baldazzi","year":"2010","journal-title":"Urol Oncol"},{"key":"10.1016\/j.steroids.2011.02.012_bib0110","doi-asserted-by":"crossref","DOI":"10.1007\/s00345-010-0627-2","article-title":"Hypothyroid correlates with a better prognosis in metastatic renal cancer patients treated with sorafenib or sunitinib","author":"Riesenbeck","year":"2010","journal-title":"World J Urol"},{"key":"10.1016\/j.steroids.2011.02.012_bib0115","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10456-008-9110-8","article-title":"Novel function of the thyroid hormone analog tetraiodothyroacetic acid: a cancer chemosensitizing and anti-cancer agent","volume":"11","author":"Rebbaa","year":"2008","journal-title":"Angiogenesis"},{"key":"10.1016\/j.steroids.2011.02.012_bib0120","first-page":"3825","article-title":"Tetraiodothyroacetic acid (tetrac) and tetrac nanoparticles inhibit growth of human renal cell carcinoma","volume":"29","author":"Yalcin","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.steroids.2011.02.012_bib0125","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1210\/jc.2009-1926","article-title":"Tetraiodothyroacetic acid (tetrac) and nanoparticulate tetrac arrest growth of human medullary carcinoma of the thyroid","volume":"95","author":"Yalcin","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.02.012_bib0130","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jsbmb.2008.12.010","article-title":"Androgen-induced human breast cancer cell proliferation is mediated by discrete mechanisms in estrogen receptor-\u03b1-positive and -negative breast cancer cells","volume":"113","author":"Lin","year":"2009","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.steroids.2011.02.012_bib0135","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1210\/me.2008-0160","article-title":"Steroidal androgens and nonsteroidal, tissue-selective androgen receptor modulator, S-22, regulate androgen receptor function through distinct genomic and nongenomic signaling pathways","volume":"22","author":"Narayanan","year":"2008","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.steroids.2011.02.012_bib0140","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1210\/jc.2004-0801","article-title":"Membrane androgen receptor activation induces apoptotic regression of human prostate cancer cells in vitro and in vivo","volume":"90","author":"Hatzoglou","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.02.012_bib0145","doi-asserted-by":"crossref","first-page":"C1250","DOI":"10.1152\/ajpcell.00410.2010","article-title":"Editorial focus: roles and controls of mTOR in the heart","volume":"299","author":"Davis","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.steroids.2011.02.012_bib0150","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1210\/en.2007-0099","article-title":"Rapamycin prevents thyroid hormone-induced cardiac hypertrophy","volume":"148","author":"Kuzman","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2011.02.012_bib0155","doi-asserted-by":"crossref","first-page":"20666","DOI":"10.1074\/jbc.M512671200","article-title":"Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways","volume":"281","author":"Kennessey","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.steroids.2011.02.012_bib0160","first-page":"290","article-title":"Testosterone induces cardiomyocyte hypertrophy through mammalian target of rapamycin complex 1 pathway","volume":"202","author":"Altamirano","year":"2009","journal-title":"J Endocrinol"},{"key":"10.1016\/j.steroids.2011.02.012_bib0165","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/me.2004-0093","article-title":"Thyroid hormone induces rapid activation of Akt\/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts","volume":"19","author":"Cao","year":"2005","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.steroids.2011.02.012_bib0170","doi-asserted-by":"crossref","first-page":"20666","DOI":"10.1074\/jbc.M512671200","article-title":"Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6k pathways","volume":"281","author":"Kennessey","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.steroids.2011.02.012_bib0175","doi-asserted-by":"crossref","first-page":"11331","DOI":"10.1158\/0008-5472.CAN-06-1540","article-title":"The PTEN\/Akt pathway dictates the direct \u03b1v\u03b23-dependent growth-inhibitory action of an active fragment of tumstatin in glioma cells in vitro and in vivo","volume":"66","author":"Kawaguchi","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.steroids.2011.02.012_bib0180","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.yjmcc.2007.09.009","article-title":"Short term triiodo-L-thyronine treatment inhibits cardiac myocyte apoptosis in border area after myocardial infarction in rats","volume":"44","author":"Chen","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.steroids.2011.02.012_bib0185","first-page":"717","article-title":"Detrimental effects of testosterone on post-myocardial infarction remodeling in female rats","volume":"58","author":"Frantz","year":"2007","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.steroids.2011.02.012_bib0190","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1210\/me.2009-0402","article-title":"Androgen receptor counteracts doxorubicin-induced cardiotoxicity in male mice","volume":"24","author":"Ikeda","year":"2010","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.steroids.2011.02.012_bib0195","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/CIRCULATIONAHA.108.799700","article-title":"Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway","volume":"119","author":"Zhu","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.steroids.2011.02.012_bib0200","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0003-4975(96)00102-6","article-title":"Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations","volume":"61","author":"Klemperer","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.steroids.2011.02.012_bib0205","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1677\/joe.0.1660173","article-title":"Tri-iodothyronine induces proliferation in cultured bovine thyroid cells: evidence for the involvement of epidermal growth factor-associated tyrosine kinase activity","volume":"166","author":"Di Fulvio","year":"2000","journal-title":"J Endocrinol"},{"key":"10.1016\/j.steroids.2011.02.012_bib0210","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/thy.2009.0249","article-title":"Tetraiodothyroacetic acid (tetrac) and tetrac nanoparticles effectively inhibit growth of human follicular thyroid carcinoma","volume":"20","author":"Yalcin","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.steroids.2011.02.012_bib0215","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1210\/en.2003-0742","article-title":"Disparate effects of thyroid hormone on EGF and TGF-\u03b1 are mediated by cyclic AMP-dependent protein kinase II","volume":"145","author":"Shih","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2011.02.012_bib0220","first-page":"1067","article-title":"Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors \u03b1 and \u03b2","volume":"36","author":"Kumar","year":"2010","journal-title":"Int J Oncol"},{"key":"10.1016\/j.steroids.2011.02.012_bib0225","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1177\/000313480907500908","article-title":"Expression of estrogen receptor, progesterone receptor, and vascular endothelial growth factor-A in thyroid cancer","volume":"75","author":"Kansakar","year":"2009","journal-title":"Am Surg"},{"key":"10.1016\/j.steroids.2011.02.012_bib0230","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0002-9610(05)80729-9","article-title":"Prognostic factors in differentiated carcinoma of the thyroid gland","volume":"164","author":"Shah","year":"1992","journal-title":"Am J Surg"},{"key":"10.1016\/j.steroids.2011.02.012_bib0235","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1365-2265.2006.02623.x","article-title":"Disparities between male and female patients with thyroid cancers: sex different or gender divide?","volume":"65","author":"Macheris","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.steroids.2011.02.012_bib0240","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/sj.bjc.6601902","article-title":"Oestrogen inhibits resveratrol-induced post-translational modification of p53 and apoptosis in breast cancer cells","volume":"91","author":"Zhang","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.steroids.2011.02.012_bib0245","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/carcin\/bgm239","article-title":"Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: both actions are integrin and ERK mediated","volume":"29","author":"Lin","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.steroids.2011.02.012_bib0250","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.4161\/cc.8.12.8747","article-title":"The pro-apoptotic action of stilbene-induced COX-2 in cancer cells: convergence with the anti-apoptotic effect of thyroid hormone","volume":"8","author":"Lin","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.steroids.2011.02.012_bib0255","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1002\/jcb.21772","article-title":"Resveratrol causes COX-2- and p53-dependent apoptosis in head and neck squamous cell cancer cells","volume":"104","author":"Lin","year":"2008","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.steroids.2011.02.012_bib0260","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1021\/bi001978b","article-title":"Thyroid hormone promotes serine phosphorylation of p53 by mitogen-activated protein kinase","volume":"40","author":"Shih","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.steroids.2011.02.012_bib0345","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2174\/138945006776359331","article-title":"Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer","volume":"7","author":"Delmas","year":"2006","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.steroids.2011.02.012_bib0270","doi-asserted-by":"crossref","DOI":"10.2174\/138920110793262079","article-title":"Resveratrol: a multifunctional cytoprotective molecule","author":"Juhasz","year":"2010","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.steroids.2011.02.012_bib0275","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1073\/pnas.0501042102","article-title":"Thyroid hormone can increase estrogen-mediated transcription from a consensus estrogen response element in neuroblastoma cells","volume":"102","author":"Zhao","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.steroids.2011.02.012_bib0280","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000054698","article-title":"Differential interaction of estrogen receptor and thyroid hormone receptor isoforms on the rat oxytocin receptor promoter leads to differences in transcriptional regulation","volume":"74","author":"Vasudevan","year":"2001","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.steroids.2011.02.012_bib0285","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2826.2001.00693.x","article-title":"Crosstalk between oestrogen receptors and thyroid hormone receptor isoforms results in differential regulation of the preproenkephalin gene","volume":"13","author":"Vasudevan","year":"2001","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.steroids.2011.02.012_bib0290","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1210\/en.2008-1503","article-title":"The xenoestrogen bisphenol A inhibits postembryonic vertebrate development by antagonizing gene regulation by thyroid hormone","volume":"150","author":"Heimeier","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2011.02.012_bib0295","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ygcen.2010.02.016","article-title":"Amphibian metamorphosis as a model for studying endocrine disruption on vertebrate development: effect of bisphenol A on thyroid hormone action","volume":"168","author":"Heimeier","year":"2010","journal-title":"Gen Comp Endocrinol"},{"key":"10.1016\/j.steroids.2011.02.012_bib0300","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.tiv.2009.05.004","article-title":"Anti-thyroid hormone activity of bisphenol A, tetrabromobisphenol A and tetrachlorobisphenol A in an improved reporter gene assay","volume":"23","author":"Sun","year":"2009","journal-title":"Toxicol in Vitro"},{"key":"10.1016\/j.steroids.2011.02.012_bib0305","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ygcen.2007.09.009","article-title":"acts differently from and independently of thyroid hormone in suppressing thyrotropin release from the bullfrog pituitary","volume":"155","author":"Kaneko","year":"2008","journal-title":"Gen Comp Endocrinol"},{"key":"10.1016\/j.steroids.2011.02.012_bib0310","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0167-4889(84)90024-7","article-title":"Thyroid hormone. Aldosterone antagonism in cultured epithelial cells","volume":"805","author":"Pratt","year":"1984","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.steroids.2011.02.012_bib0315","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0303-7207(93)90102-P","article-title":"Triiodothyronine (T3) modulates hCG-regulated progesterone secretion, cAMP accumulation and DNA content in cultured human luteinized granulosa cells","volume":"96","author":"Goldman","year":"1993","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.steroids.2011.02.012_bib0320","first-page":"141","article-title":"Role of co-activators and co-repressors in the mechanism of steroid\/thyroid receptor action","volume":"52","author":"Shibata","year":"1997","journal-title":"Recent Progr Horm Res"},{"key":"10.1016\/j.steroids.2011.02.012_bib0325","unstructured":"Lin HY, Tang HY, Lin C, Sun M, Davis FB, Davis PJ. Thyroid hormone induces nuclear accumulation of monomeric integrin \u03b1v and formation of integrin-nucleoprotein complexes. Program of the 79th annual meeting of the American Thyroid Association. Thyroid 2007;(Suppl 1):abstract 261."},{"key":"10.1016\/j.steroids.2011.02.012_bib0330","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/BF03344022","article-title":"Comparison of the mechanisms of nongenomic actions of thyroid hormone and steroid hormones","volume":"25","author":"Davis","year":"2002","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.steroids.2011.02.012_bib0335","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.tem.2009.06.009","article-title":"Plasma membrane estrogen receptors","volume":"20","author":"Levin","year":"2009","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.02.012_bib0340","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10549-007-9618-4","article-title":"Estrogen receptors outside the nucleus in breast cancer","volume":"108","author":"Levin","year":"2008","journal-title":"Breast Cancer Res Treat"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X11000523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X11000523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T15:07:43Z","timestamp":1637334463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X11000523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":68,"alternative-id":["S0039128X11000523"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2011.02.012","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}